Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Farde

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 12, 2025
In vivo quantification of [<sup>11</sup>C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcaseMartin Bolin, Sangram Nag, Ryosuke Arakawa, et al.
Biological Psychiatry|February 9, 2010
Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memoryHåkan Fischer, Lars Nyberg, Sari Karlsson, et al.
Synapse (New York, N.Y.)|March 23, 2023
[<sup>11</sup> C]PBB3 binding in Aβ(-) or Aβ(+) corticobasal syndromeZsolt Cselényi, Johan Wallin, Jonathan Tjerkaski, et al.
Molecular Imaging and Biology|March 17, 2026
The Binding of the High Affinity Radioligand Fallypride to the D2-dopamine Receptor is Sensitive to Injected Mass - a PET Study in RodentsMiklós Tóth, Lenke Tari, Sangram Nag, et al.
Nuclear Medicine and Biology|February 15, 2011
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compoundsJan D Andersson, M Edward Pierson, Sjoerd J Finnema, et al.
The American Journal of Psychiatry|June 1, 2004
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophreniaFumihiko Yasuno, Tetsuya Suhara, Yoshiro Okubo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligandZsolt Cselényi, Maria Eriksdotter Jönhagen, Anton Forsberg, et al.
Journal of the Neurological Sciences|March 12, 2005
[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studiesBalázs Gulyás, Christer Halldin, Adám Vas, et al.
The International Journal of Neuropsychopharmacology|September 16, 2017
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate BrainKai-Chun Yang, Vladimir Stepanov, Stefan Martinsson, et al.
Nuclear Medicine and Biology|September 18, 2002
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporterJohan Sandell, Christer Halldin, Judith Sovago, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 12, 2025
In vivo quantification of [<sup>11</sup>C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcaseMartin Bolin, Sangram Nag, Ryosuke Arakawa, et al.
Biological Psychiatry|February 9, 2010
Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memoryHåkan Fischer, Lars Nyberg, Sari Karlsson, et al.
Synapse (New York, N.Y.)|March 23, 2023
[<sup>11</sup> C]PBB3 binding in Aβ(-) or Aβ(+) corticobasal syndromeZsolt Cselényi, Johan Wallin, Jonathan Tjerkaski, et al.
Molecular Imaging and Biology|March 17, 2026
The Binding of the High Affinity Radioligand Fallypride to the D2-dopamine Receptor is Sensitive to Injected Mass - a PET Study in RodentsMiklós Tóth, Lenke Tari, Sangram Nag, et al.
Nuclear Medicine and Biology|February 15, 2011
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compoundsJan D Andersson, M Edward Pierson, Sjoerd J Finnema, et al.
The American Journal of Psychiatry|June 1, 2004
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophreniaFumihiko Yasuno, Tetsuya Suhara, Yoshiro Okubo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligandZsolt Cselényi, Maria Eriksdotter Jönhagen, Anton Forsberg, et al.
Journal of the Neurological Sciences|March 12, 2005
[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studiesBalázs Gulyás, Christer Halldin, Adám Vas, et al.
The International Journal of Neuropsychopharmacology|September 16, 2017
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate BrainKai-Chun Yang, Vladimir Stepanov, Stefan Martinsson, et al.
Nuclear Medicine and Biology|September 18, 2002
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporterJohan Sandell, Christer Halldin, Judith Sovago, et al.
Pageof 22